Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Homo sapiens | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Leishmania major | peptidyl-prolyl cis-trans isomerase, putative | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 163 aa | 133 aa | 27.8 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.1263 | 0.1263 |
Echinococcus granulosus | expressed protein | 0.004 | 0.5783 | 0.827 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.6992 | 0.6897 |
Schistosoma mansoni | inositol monophosphatase | 0.0037 | 0.511 | 0.6716 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0033 | 0.4284 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.1263 | 0.1807 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.2981 | 0.2981 |
Echinococcus granulosus | lamin dm0 | 0.0027 | 0.2981 | 0.4263 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase | 0.0039 | 0.5581 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.6992 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0027 | 0.2981 | 0.4263 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.1263 | 0.0988 |
Echinococcus multilocularis | expressed protein | 0.004 | 0.5783 | 0.827 |
Echinococcus multilocularis | musashi | 0.0027 | 0.2981 | 0.4263 |
Trypanosoma brucei | peptidyl-prolyl cis-trans isomerase/rotamase, putative | 0.0039 | 0.5581 | 1 |
Echinococcus multilocularis | lamin | 0.0027 | 0.2981 | 0.4263 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 1 | 1 |
Trypanosoma cruzi | peptidyl-prolyl cis-trans isomerase | 0.0039 | 0.5581 | 1 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0033 | 0.4284 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.6992 | 0.6992 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.6992 | 1 |
Onchocerca volvulus | 0.0027 | 0.2981 | 0.5 | |
Schistosoma mansoni | lamin | 0.0027 | 0.2981 | 0.2998 |
Loa Loa (eye worm) | Pin1-type peptidyl-prolyl cis-trans isomerase | 0.004 | 0.5783 | 0.5783 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.5956 | 0.8192 |
Echinococcus granulosus | lamin | 0.0027 | 0.2981 | 0.4263 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 0.2981 | 0.2981 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.1263 | 0.1807 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.6992 | 1 |
Entamoeba histolytica | peptidyl-prolyl cis-trans isomerase, putative | 0.0039 | 0.5581 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.1263 | 0.1807 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.6992 | 1 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0037 | 0.511 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0027 | 0.2981 | 0.2998 |
Brugia malayi | Inositol-1 | 0.0037 | 0.511 | 0.4956 |
Schistosoma mansoni | rotamase | 0.004 | 0.5783 | 0.7889 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0306 | 0.0306 |
Leishmania major | peptidyl-prolyl cis-trans isomerase/rotamase, putative,PPIase, putative | 0.0039 | 0.5581 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.6992 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.6992 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.2876 | 0.2876 |
Trichomonas vaginalis | conserved hypothetical protein | 0.004 | 0.5783 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.1263 | 0.1263 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 0.2981 | 0.2759 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 0.2981 | 0.2981 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.1263 | 0.0988 |
Schistosoma mansoni | inositol monophosphatase | 0.0037 | 0.511 | 0.6716 |
Onchocerca volvulus | 0.0027 | 0.2981 | 0.5 | |
Brugia malayi | Pin1-type peptidyl-prolyl cis-trans isomerase, BmPin1 | 0.004 | 0.5783 | 0.565 |
Trichomonas vaginalis | rotamase, putative | 0.0039 | 0.5581 | 0.7 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0037 | 0.511 | 0.7309 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.5956 | 0.5829 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0037 | 0.511 | 0.5 |
Trichomonas vaginalis | rotamase, putative | 0.004 | 0.5783 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 1 | 1 |
Toxoplasma gondii | peptidylprolyl isomerase | 0.0039 | 0.5581 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.1263 | 0.1807 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.1263 | 0.1807 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.6992 | 1 |
Schistosoma mansoni | lamin | 0.0027 | 0.2981 | 0.2998 |
Echinococcus granulosus | intermediate filament protein | 0.0027 | 0.2981 | 0.4263 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0037 | 0.511 | 0.7309 |
Brugia malayi | intermediate filament protein | 0.0027 | 0.2981 | 0.2759 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.5956 | 0.5956 |
Loa Loa (eye worm) | inositol-1 | 0.0037 | 0.511 | 0.511 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.1263 | 0.1807 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (binding) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.